Marko Hyvonen
Affiliations: | University of Cambridge, Cambridge, England, United Kingdom |
Area:
Structural biology, biophysics, biochemistry, fragment-based drug discoveryGoogle:
"Marko Hyvonen"Children
Sign in to add trainee| Adrian Harrington | grad student | 2002-2006 | Cambridge |
| Ye Gu | grad student | 2008-2012 | Cambridge |
| Emily Blythe | grad student | 2012-2013 | Cambridge |
| Jane Cat Donaldson | grad student | 2009-2014 | Cambridge |
| Miglė Kišonaitė | grad student | 2014-2015 | Cambridge |
| Xuelu Wang | grad student | 2012-2016 | Cambridge |
| Ruoqi-Emma Xu | grad student | 2012-2016 | Cambridge |
| Clare Henry | grad student | 2013-2017 | Cambridge |
| Margherite Guiata | grad student | 2016-2017 | Cambridge |
| Thomas Cotton | grad student | 2015-2019 | Cambridge |
| Joseph McLoughlin | grad student | 2015-2019 | Cambridge |
| Richard Zhou | grad student | 2019-2020 | Cambridge |
| Teodors Pantelejevs | grad student | 2015-2021 | Cambridge |
| Matthew Ratcliff | grad student | 2016-2021 | Cambridge |
Collaborators
Sign in to add collaborator| Florian Hollfelder | collaborator | 2005- | Cambridge (Chemistry Tree) |
| David Spring | collaborator | 2010- | Cambridge (Chemistry Tree) |
| Andrea Balan | collaborator | 2016- | University of São Paulo - Institute of Biomedical Science |
| Morten Grotli | collaborator | 2018- | University of Gothenburg, Sweden |
| Christopher Abell | collaborator | 2004-2020 | University of Cambridge (UK) (Chemistry Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Stockwell SR, Scott DE, Fischer G, et al. (2024) Selective Aurora A-TPX2 Interaction Inhibitors Have Efficacy as Targeted Antimitotic Agents. Journal of Medicinal Chemistry |
| Fischer K, Lulla A, So TY, et al. (2024) Rapid discovery of monoclonal antibodies by microfluidics-enabled FACS of single pathogen-specific antibody-secreting cells. Nature Biotechnology |
| Pantelejevs T, Zuazua-Villar P, Koczy O, et al. (2023) A recombinant approach for stapled peptide discovery yields inhibitors of the RAD51 recombinase. Chemical Science. 14: 13915-13923 |
| Cioffi VB, de Castro-Amarante MF, Lulla A, et al. (2023) SARS-CoV-2 Spike protein peptides displayed in the Pyrococcus furiosus RAD system preserve epitopes antigenicity, immunogenicity, and virus-neutralizing activity of antibodies. Scientific Reports. 13: 16821 |
| Yam-Puc JC, Hosseini Z, Horner EC, et al. (2023) Age-associated B cells predict impaired humoral immunity after COVID-19 vaccination in patients receiving immune checkpoint blockade. Nature Communications. 14: 3292 |
| Dimitrijevs P, Makrecka-Kuka M, Bogucka A, et al. (2023) Development of isoselenazolium chlorides as selective pyruvate kinase isoform M2 inhibitors. European Journal of Medicinal Chemistry. 257: 115504 |
| Knyphausen P, Rangel Pereira M, Brear P, et al. (2023) Evolution of protease activation and specificity via alpha-2-macroglobulin-mediated covalent capture. Nature Communications. 14: 768 |
| Nain-Perez A, Nilsson O, Lulla A, et al. (2023) Tuning liver pyruvate kinase activity up or down with a new class of allosteric modulators. European Journal of Medicinal Chemistry. 250: 115177 |
| Brear P, De Fusco C, Atkinson EL, et al. (2022) A fragment-based approach leading to the discovery of inhibitors of CK2α with a novel mechanism of action. Rsc Medicinal Chemistry. 13: 1420-1426 |
| Battisti UM, Gao C, Nilsson O, et al. (2022) Serendipitous Identification of a Covalent Activator of Liver Pyruvate Kinase. Chembiochem : a European Journal of Chemical Biology |